Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children

Journal of Pediatrics

Volumn 160, Issue 1, 2012, Pages 74-81

  Long, Caroline B ^a   Ramos, Irene ^b   Rastogi, Deepa ^a   Manwani, Deepa ^a   Janow, Ginger ^a   Del Rio, Marcela ^a   Mayers, Marguerite ^a   Herold, Betsy C ^a   Fernandez Sesma, Ana ^b   Madan, Rebecca Pellett ^a  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; ASTHMA; BLOOD SAMPLING; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA; SICKLE CELL ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; CHILD; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; RISK FACTORS;

EID: 82955248039     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2011.06.045     Document Type: Article

References (30)

1. R. Libster, J. Bugna, S. Coviello, D.R. Hijano, M. Dunaiewsky, and N. Reynoso Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina N Engl J Med 362 2010 45 55
2. D.G. Bundy, J.J. Strouse, J.F. Casella, and M.R. Miller Burden of influenza-related hospitalizations among children with sickle cell disease Pediatrics 125 2010 234 243
3. B. Wang, D.E. Dwyer, C.C. Blyth, M. Soedjono, H. Shi, and A. Kesson Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections Antiviral Res 87 2010 16 21
4. X.F. Liang, H.Q. Wang, J.Z. Wang, H.H. Fang, J. Wu, and F.C. Zhu Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 375 2010 56 66
5. A. Arguedas, C. Soley, and K. Lindert Responses to 2009 H1N1 vaccine in children 3 to 17 years of age N Engl J Med 362 2010 370 372
6. T. Nolan, J. McVernon, M. Skeljo, P. Richmond, U. Wadia, and S. Lambert Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial JAMA 303 2010 37 46
7. E. Plennevaux, E. Sheldon, M. Blatter, M.K. Reeves-Hoche, and M. Denis Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials Lancet 375 2010 41 48
8. W.P. Glezen, L.S. Glezen, and R. Alcorn Trivalent, inactivated influenza virus vaccine in children with sickle cell disease Am J Dis Child 137 1983 1095 1097 (Pubitemid 13021599)
9. O.F. Ballester, J.M. Abdallah, and A.S. Prasad Impaired IgM antibody responses to an influenza virus vaccine in adults with sickle cell anemia Am J Hematol 20 1985 409 412 (Pubitemid 16222308)
10. R.P. Madan, M. Tan, A. Fernandez-Sesma, T.M. Moran, S. Emre, and A. Campbell A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings Clin Infect Dis 46 2008 712 718 (Pubitemid 351321555)
11. A. Holvast, S. van Assen, A. de Haan, A. Huckriede, C.A. Benne, and J. Westra Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus Arthritis Rheum 60 2009 2438 2447
12. C.L. Park, A.L. Frank, M. Sullivan, P. Jindal, and B.D. Baxter Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy Pediatrics 98 1996 196 200 (Pubitemid 26262129)
13. T.D. Bell, H. Chai, B. Berlow, and G. Daniels Immunization with killed influenza virus in children with chronic asthma Chest 73 1978 140 145 (Pubitemid 8292795)
14. J.R. Groothuis, M.V. Lehr, and M.J. Levin Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children Vaccine 12 1994 139 141 (Pubitemid 24041931)
15. J. Treanor, and P.F. Wright Immune correlates of protection against influenza in the human challenge model Dev Biol (Basel) 115 2003 97 104
16. W. Liu, S.J. de Vlas, F. Tang, M.J. Ma, M.T. Wei, and L.J. Liu Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination Clin Infect Dis 51 2010 1028 1032
17. X.S. He, T.H. Holmes, K. Mahmood, G.W. Kemble, C.L. Dekker, and A.M. Arvin Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines J Infect Dis 197 2008 803 811 (Pubitemid 351417002)
18. X.S. He, T.H. Holmes, S. Sasaki, M.C. Jaimes, G.W. Kemble, and C.L. Dekker Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines PLoS One 3 2008 e2574
19. J.L. Sever Application of a microtechnique to viral serological investigations J Virol 88 1962 320 329
20. D.L. Noah, H. Hill, D. Hines, E.L. White, and M.C. Wolff Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure Clin Vaccine Immunol 16 2009 558 566
21. F.C. Zhu, H. Wang, H.H. Fang, J.G. Yang, X.J. Lin, and X.F. Liang A novel influenza A (H1N1) vaccine in various age groups N Engl J Med 361 2009 2414 2423
22. M.M. Levine, T.P. Hughes, P. Simon, S. O'Donnell, S. Grauel, and S.G. Levine Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years J Infect Dis 136 SUPPL. 1977 S571 S574 (Pubitemid 8293904)
23. J.A. Englund, E.B. Walter, A. Gbadebo, A.S. Monto, Y. Zhu, and K.M. Neuzil Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers Pediatrics 118 2006 e579 e585 (Pubitemid 46091609)
24. W.A. Keitel, C.L. Dekker, C. Mink, J.D. Campbell, K.M. Edwards, and S.M. Patel Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults Vaccine 27 2009 6642 6648
25. R.B. Couch, P. Winokur, R. Brady, R. Belshe, W.H. Chen, and T.R. Cate Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects Vaccine 25 2007 7656 7663 (Pubitemid 47554468)
26. A.R. Falsey, J.J. Treanor, N. Tornieporth, J. Capellan, and G.J. Gorse Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older J Infect Dis 200 2009 172 180
27. J.M. Benito, M. Lopez, S. Lozano, C. Ballesteros, J. Gonzalez-Lahoz, and V. Soriano Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation Clin Exp Immunol 149 2007 171 177 (Pubitemid 46897113)
28. M.P. Fairchok, D.P. Trementozzi, P.S. Carter, H.L. Regnery, and E.R. Carter Effect of prednisone on response to influenza virus vaccine in asthmatic children Arch Pediatr Adolesc Med 152 1998 1191 1195 (Pubitemid 28558105)
29. C.C. Lu, Y.C. Wang, J.H. Lai, T.S. Lee, H.T. Lin, and D.M. Chang A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity Vaccine 29 2011 444 450
30. A.M. Zeman, T.H. Holmes, S. Stamatis, W. Tu, X.S. He, and N. Bouvier Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine Pediatr Infect Dis J 26 2007 107 115 (Pubitemid 46183359)